Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 25 July 2024 31 July 2025 31 July 2025 15858071 Dr Issac Goh iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15858071 2024-07-24 15858071 2025-07-31 15858071 2024-07-25 2025-07-31 15858071 frs-core:CurrentFinancialInstruments 2025-07-31 15858071 frs-bus:PrivateLimitedCompanyLtd 2024-07-25 2025-07-31 15858071 frs-bus:FilletedAccounts 2024-07-25 2025-07-31 15858071 frs-bus:Micro-entities 2024-07-25 2025-07-31 15858071 frs-bus:AuditExempt-NoAccountantsReport 2024-07-25 2025-07-31 15858071 frs-bus:Director1 2024-07-25 2025-07-31
Registered number: 15858071
AtlasBiomics Ltd
Unaudited Financial Statements
For the Period 25 July 2024 to 31 July 2025
Parry and Parry Limited
3 Wellington Court
Wellington Street
Cambridge
CB1 1HZ
AtlasBiomics Ltd
Balance Sheet
As At 31 July 2025
Balance Sheet
Registered number: 15858071

| 31 July 2025
--- | ---
|  | £
Fixed assets |  | 2,028
Current assets |  | 1,953
Creditors: Amounts Falling Due Within One Year |  | (5,896 )
NET CURRENT LIABILITIES |  | (3,943 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  | (1,915 )
NET LIABILITIES |  | (1,915 )
CAPITAL AND RESERVES |  | (1,915 )

## Notes

1. General Information
AtlasBiomics Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15858071. The registered office is 14a Haldane Terrace, Newcastle upon Tyne NE2 3AN.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Issac Goh Director
09/10/2025